Last reviewed · How we verify
NCT04238559: SWAMECO
Use of the SWAMECO Questionnaire Basel
trial testing Self-report questionnaire in Swallowing Difficulties in 115 participants. Completed in 9 April 2019.
9 April 2019
Quick facts
| Lead sponsor | University Hospital, Basel, Switzerland |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 115 |
| Start date | 11 February 2019 |
| Primary completion | 9 April 2019 |
| Estimated completion | 9 April 2019 |
| Sites | 1 location across Switzerland |
Drugs / interventions tested
- Self-report questionnaire
Conditions studied
- Swallowing Difficulties — all drugs for Swallowing Difficulties →
Sponsor
University Hospital, Basel, Switzerland
Who can join
18 and older, any sex, with Swallowing Difficulties. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
A patient self-report questionnaire was developed that assesses subjective swallowing difficulties with medication intake, the SWAMECO questionnaire. It was validated in a highly specific population and will now be tested in the general population.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT04238559
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Self-report questionnaire
Trials testing the same drug.
- NCT04711733 — Supportive Care Needs of Former Child, AYA Cancer Patients, and of Their Parents: Evaluation During Long-term Follow-up · completed
Other recruiting trials for Swallowing Difficulties
Currently open trials in the same condition.
- NCT06893458 — Feeding Difficulties and Quality of Life in Children With Tracheal Cannula · recruiting
- NCT07021586 — Tongue Pressure in Middle-Aged and Elderly Individuals With Chronic Cervical Pain · recruiting
Other University Hospital, Basel, Switzerland trials
Trials by the same sponsor.
- NCT07444788 — Acute Effects of Intravenous 5-MeO-DMT in Healthy Participants · Phase 1 · recruiting
- NCT07494214 — Acute Analgesic Effects of MDMA on Experimentally Induced Acute Pain, Hyperalgesia and Allodynia in Healthy Participants · Phase 1 · recruiting
- NCT07419048 — Artificial Intelligence or Human Hand? Evaluating Inferior Vena Cava Imaging for Hydration Status · recruiting
- NCT06978777 — Effect of Caffeine on Cold-stimulated Brown Adipose Tissue Activity · NA · recruiting
- NCT07273630 — Effect of Protein Supplementation and Fluid Restriction on Plasma Sodium Levels in Patients Undergoing Pituitary Surgery · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04238559 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University Hospital, Basel, Switzerland
- Last refreshed: 29 January 2020
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04238559.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing